H-1B sponsorship profile: Allogene Therapeutics, Inc. Across U.S. Department of Labor LCA disclosures, Allogene Therapeutics, Inc filed 6 Labor Condition Applications covering 6 H-1B worker positions between fiscal year 2023 and fiscal year 2026. The employer’s DOL certification rate sits at 100% (6 certified of 6 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Allogene Therapeutics, Inc’s H-1B petitions range from $129,016 at the low end to $224,687 at the high end, with a petition-weighted average of $176,098. That range reflects the mix of occupations the company sponsors, led by Senior Manager, Quality and Regulatory Systems (3 petitions at $206,876 avg), followed by Senior Scientist and Scientist, Process Development. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Allogene Therapeutics, Inc is headquartered in South San Francisco, CA under NAICS code 541714, and places H-1B workers across 1 state, most heavily in CA. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Allogene Therapeutics, Inc ranks. By H-1B petition volume, Allogene Therapeutics, Inc is #23,486 of 119,880 employers nationally and #3,893 of 22,893 employers headquartered in CA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.